161 related articles for article (PubMed ID: 34055841)
1. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis.
Wang QF; Wang QL; Cao MB
Front Med (Lausanne); 2021; 8():668787. PubMed ID: 34055841
[No Abstract] [Full Text] [Related]
2. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
Sun J; Zhang Y; Li B; Dong Y; Sun C; Zhang F; Jin L; Chen D; Wang W
Cell Death Dis; 2019 Nov; 10(11):844. PubMed ID: 31700026
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
Peng BH; Ji YF; Qiu XJ
J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
[TBL] [Abstract][Full Text] [Related]
4. lncRNA PITPNA-AS1 promotes cell proliferation and metastasis in hepatocellular carcinoma by upregulating PDGFD.
Yao J; Liu X
Aging (Albany NY); 2023 Mar; 15(10):4071-4083. PubMed ID: 37253627
[TBL] [Abstract][Full Text] [Related]
5. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PITPNA-AS1 regulates UNC5B expression in papillary thyroid cancer via sponging miR-129-5p.
Mei S; Zong H; Zhou H
Int J Biol Markers; 2021 Mar; 36(1):10-19. PubMed ID: 33706585
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA
Yuan C; Yang L
Cancer Manag Res; 2020; 12():12497-12507. PubMed ID: 33312000
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DNAJC3-AS1 Promotes Hepatocellular Carcinoma (HCC) Progression via Sponging Premature miR-27b.
Fu C; Li J; Li P; Cheng D
Cancer Manag Res; 2021; 13():8575-8583. PubMed ID: 34815712
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
[TBL] [Abstract][Full Text] [Related]
14. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
15. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis.
Fei Q; Song F; Jiang X; Hong H; Xu X; Jin Z; Zhu X; Dai B; Yang J; Sui C; Xu M
Cancer Cell Int; 2020; 20():232. PubMed ID: 32536820
[TBL] [Abstract][Full Text] [Related]
16. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
Geng S; Tu S; Fu W; Wang J; Bai Z
Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.
Lu YB; Jiang Q; Yang MY; Zhou JX; Zhang Q
Oncotarget; 2017 Oct; 8(51):88804-88814. PubMed ID: 29179477
[TBL] [Abstract][Full Text] [Related]
18. STAT1-induced upregulation of lncRNA RHPN1-AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR-485/CDCA5 axis.
Zhang X; Yan Z; Wang L; Zhang S; Gao M
J Cell Biochem; 2020 Dec; 121(12):4741-4755. PubMed ID: 32065447
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
